Relafen Trademark Details

Relafen was registered on Tuesday, August 16, 1983 and is currently owned by Glaxosmithkline LLC under the registration number 1248125 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 9 years ago on Tuesday, September 9, 2014, according to the United State Patent & Trademark Office
Word Mark Relafen
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Glaxosmithkline LLC of Wilmington, DE

View all trademarks for Glaxosmithkline LLC
Other Trademarks for Glaxosmithkline LLC

Previous Owners

Beecham Inc. of Clifton, NJ

View all trademarks for Beecham Inc.
Other Trademarks for Beecham Inc.

Smithkline Beecham Corporation of Philadelphia, PA

View all trademarks for Smithkline Beecham Corporation
Other Trademarks for Smithkline Beecham Corporation
Serial Number 73353073
Registration Number 1248125
Status Date Tuesday, September 9, 2014
Filing Date Tuesday, September 9, 2014
Registration Date Tuesday, August 16, 1983
Attorney Christopher M. Hanes
Domestic Representative Christopher M. Hanes

Correspondent

Christopher M. Hanes
GlaxoSmithKline
Five Moore Drive
LGTM, C.3157.3D
Research Triangle Park NC 27709

Case File Statements

Goods & Services Pharmaceutical Preparation for Human Use-Namely, an Anti-Inflammatory Agent

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 018
Status 2 — Sec. 8 – Entire Registration
Status Date Tuesday, September 9, 2014
First Use Anywhere Wednesday, February 17, 1982
First Use In Commerce Wednesday, February 17, 1982
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.